Global Mechanical Circulatory Support (MCS) Devices Market : Global Market Estimation, Dynamics, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Mechanical Circulatory Support (MCS) Devices Market: By Product Type (Ventricular Assist Devices, Left Ventricular Assist Devices (LVAD), Biventricular Ventricular Assist Devices (BIVAD), Right Ventricular Assist Devices (RVAD), Artificial Heart, Extracorporeal Membrane Oxygenation, and Intra-Aortic Balloon Pumps), By End-User (Hospitals, Ambulatory Surgical Centers, and Specialty Cardiology Centers), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The mechanical circulatory support (MCS) devices market size is anticipated to be valued at USD 1,164.3 Million in 2021 and is expanded to grow at a significant CAGR of 6.7% over 2022-2028. When the heart isn’t operating correctly, a mechanical circulatory support (MCS) device can help. Patients with advanced heart or pulmonary failure may need external mechanical assistance to keep their heart pumping enough blood. Mechanical circulatory support (MCS) devices are a traditional way by which temporary or permanent support may be provided to the patients. Mechanical circulatory support devices’ technologically advanced features, such as their small size, which allows them to be implanted with minimal invasion to provide complete ventricular assistance and reduced hemolysis by providing ample circulation paths, are driving the global mechanical circulatory support devices market. Furthermore, funding from various governments will aid in the research and development of these devices, boosting the mechanical circulatory support device market even further. Due to an increase in the adoption of cardiac monitoring systems during the treatment of mechanical circulatory support (MCS) devices, the surgical segment generated the most revenue in 2020. By end-user, the hospital segment registered the highest revenue in 2021, owning to the increased adoption of laser and radiofrequency methods for catheter ablation. An increase in the number of patients with arrhythmia or an irregular heartbeat problem has resulted in a growth in demand for cardiac monitors.

Recent Market Developments:

In December 2020, Abbott announced their FDA approval for updated labeling of the company’s HeartMate 3 heart pump so that it could be used readily in pediatric patients suffering from advanced refractory left ventricular heart failure.

In Feb 2021, Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc. Transaction furthers Terumo’s efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of care

Mechanical Circulatory Support (MCS) Devices Market

MARKET SUMMARY
-
11.3% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 11.3%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Mechanical Circulatory Support (MCS) Device Market

  • The report on global Mechanical Circulatory Support (MCS) Device Market gives historical, current, and future market sizes (US$ Mn) on the basis of indication, device type and geography.
  • Mechanical Circulatory Support (MCS) Device Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Key Players
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Cardiac Assist, Inc.
  • Cardio Bridge GmbH
  • Carmat SA
Mechanical Circulatory Support (MCS) Devices Market

Dynamics

The development of Mechanical Circulatory Support devices has been driven by the shortage of donor organs. The lack of organ availability is overcome by initially keeping the patient alive through a mechanical circulatory support system (MCS) in the face of threatening heart failure (HF) until the patient can be heart transplanted or by implanting the system permanently instead of transplantation. Other factors such as patient reluctance to visit the hospitals and clinics, logistical restrictions, and the closing down of manufacturing facilities can all be considered as drawbacks to the Mechanical Circulatory Support Devices market.


North-America got significant share

Mechanical Circulatory Support (MCS) Devices Market

In the current scenario, North America tends to lead the worldwide market, and it is anticipated to continue to do so during the forecast period. The dominance of North America, on the other hand, will be challenged by the European market. The increased prevalence of cardiovascular illnesses, advantageous reimbursement rules, and the presence of all major important companies in the North American market have all contributed to this dominance.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Mechanical Circulatory Support (MCS) Devices Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The Mechanical Circulatory Support (MCS) Devices Market is projected to expand at a CAGR of 6.7% during the forecast period.

Abbott Laboratories, Teleflex Incorporated, SynCardia Systems LLC, Jude Medical Inc

Asia-Pacific is the fastest-growing region for Mechanical Circulatory Support (MCS) Devices Market


Report

Table Of Content


Report

Company Profile

  • Abbott Laboratories
  • Teleflex Incorporated
  • SynCardia Systems LLC
  • Jude Medical Inc
  • CARMAT
  • CorWave SA
  • Medtronic PLC
  • Terumo Heart, Inc.
  • NovaPump GmbH
  • Getinge AB
  • Balton Ltd.,
  • Meril Life Sciences Pvt. Ltd
  • Thoratec Corporation,

Description

The mechanical circulatory support (MCS) devices market size is anticipated to be valued at USD 1,164.3 Million in 2021 and is expanded to grow at a significant CAGR of 6.7% over 2022-2028. When the heart isn’t operating correctly, a mechanical circulatory support (MCS) device can help. Patients with advanced heart or pulmonary failure may need external mechanical assistance to keep their heart pumping enough blood. Mechanical circulatory support (MCS) devices are a traditional way by which temporary or permanent support may be provided to the patients. Mechanical circulatory support devices’ technologically advanced features, such as their small size, which allows them to be implanted with minimal invasion to provide complete ventricular assistance and reduced hemolysis by providing ample circulation paths, are driving the global mechanical circulatory support devices market. Furthermore, funding from various governments will aid in the research and development of these devices, boosting the mechanical circulatory support device market even further. Due to an increase in the adoption of cardiac monitoring systems during the treatment of mechanical circulatory support (MCS) devices, the surgical segment generated the most revenue in 2020. By end-user, the hospital segment registered the highest revenue in 2021, owning to the increased adoption of laser and radiofrequency methods for catheter ablation. An increase in the number of patients with arrhythmia or an irregular heartbeat problem has resulted in a growth in demand for cardiac monitors.

Recent Market Developments:

In December 2020, Abbott announced their FDA approval for updated labeling of the company’s HeartMate 3 heart pump so that it could be used readily in pediatric patients suffering from advanced refractory left ventricular heart failure.

In Feb 2021, Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc. Transaction furthers Terumo’s efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of care

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX